Intrinsic
Screener
Valuation
Movers
Economy
Bonds
Institutions
Business Summaries
Updates
Go
Sign In
Screener
Summaries
Updates
Institutions
Sign In
More
↑
Overview
Financials
Chart
Business Summary
Filings
Ownership
Valuation
← Scroll for more →
Compugen Ltd
(CGEN)
Biological Products, (No Diagnostic Substances)
Latest Price
$2.38
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.09
P/B Ratio
2.19
Valuation metrics
adjust assumptions →
EPS:
$0.38
Book value / share:
$1.09
Formula:
√(22.5 × EPS × BVPS)
Graham Number
$3.05
+28% upside
Base FCF:
$40M (median of recent 5yr)
Growth:
-15%/yr (median YOY, capped at 25%)
Discount rate:
10%
Terminal growth:
3%
Projection horizon:
10 years
DCF Fair Value
$2.88
+21% upside
EPS:
$0.38
Target P/E:
15×
Formula:
EPS × P/E
P/E Fair Value
$5.70
+139% upside